174 related articles for article (PubMed ID: 17825818)
1. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton.
Martín-Encabo S; Santos E; Guerrero C
Exp Cell Res; 2007 Nov; 313(18):3881-91. PubMed ID: 17825818
[TBL] [Abstract][Full Text] [Related]
2. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth.
Guerrero C; Martín-Encabo S; Fernández-Medarde A; Santos E
Oncogene; 2004 Jun; 23(28):4885-93. PubMed ID: 15077165
[TBL] [Abstract][Full Text] [Related]
3. F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.
Mitra A; Radha V
Oncogene; 2010 Aug; 29(32):4528-42. PubMed ID: 20581864
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated guanine nucleotide exchange factor C3G, induced by pervanadate and Src family kinases localizes to the Golgi and subcortical actin cytoskeleton.
Radha V; Rajanna A; Swarup G
BMC Cell Biol; 2004 Aug; 5():31. PubMed ID: 15320955
[TBL] [Abstract][Full Text] [Related]
5. Collagen type I-mediated activation of ERK/MAP Kinase is dependent on Ras, Raf-1 and protein phosphatase 2A in Jurkat T cells.
Chetoui N; Gendron S; Chamoux E; Aoudjit F
Mol Immunol; 2006 Apr; 43(10):1687-93. PubMed ID: 16266749
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton.
Harrison RE; Sikorski BA; Jongstra J
J Cell Sci; 2004 Apr; 117(Pt 10):2151-7. PubMed ID: 15090600
[TBL] [Abstract][Full Text] [Related]
7. Activation of the extracellular signal-regulated kinase by complement C5b-9.
Cybulsky AV; Takano T; Papillon J; Bijian K; Guillemette J
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F593-603. PubMed ID: 15855657
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase 2A interacts with the Src kinase substrate p130(CAS).
Yokoyama N; Miller WT
Oncogene; 2001 Sep; 20(42):6057-65. PubMed ID: 11593413
[TBL] [Abstract][Full Text] [Related]
9. Human diploid fibroblasts are resistant to MEK/ERK-mediated disruption of the actin cytoskeleton and invasiveness stimulated by Ras.
Sukezane T; Oneyama C; Kakumoto K; Shibutani K; Hanafusa H; Akagi T
Oncogene; 2005 Aug; 24(36):5648-55. PubMed ID: 16007212
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase activity and remodelling of the actin cytoskeleton are co-temporally required for degranulation by cytotoxic T lymphocytes.
Shen A; Puente LG; Ostergaard HL
Immunology; 2005 Oct; 116(2):276-86. PubMed ID: 16162276
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
12. Disruption of cell spreading by the activation of MEK/ERK pathway is dependent on AP-1 activity.
Xu F; Ito S; Hamaguchi M; Senga T
Nagoya J Med Sci; 2010 Aug; 72(3-4):139-44. PubMed ID: 20942268
[TBL] [Abstract][Full Text] [Related]
13. A critical role for the protein phosphatase 2A B'α regulatory subunit in dephosphorylation of sphingosine kinase 1.
Pitman MR; Barr RK; Gliddon BL; Magarey AM; Moretti PA; Pitson SM
Int J Biochem Cell Biol; 2011 Mar; 43(3):342-7. PubMed ID: 21075214
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 2A-negative regulation of the protective signaling pathway of Ca2+/CaM-dependent ERK activation in cerebral ischemia.
Zhao J; Wu HW; Chen YJ; Tian HP; Li LX; Han X; Guo J
J Neurosci Res; 2008 Sep; 86(12):2733-45. PubMed ID: 18478546
[TBL] [Abstract][Full Text] [Related]
15. Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN.
Han MY; Kosako H; Watanabe T; Hattori S
Mol Cell Biol; 2007 Dec; 27(23):8190-204. PubMed ID: 17875928
[TBL] [Abstract][Full Text] [Related]
16. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine.
Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ
Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187
[TBL] [Abstract][Full Text] [Related]
17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
18. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB mediated signalling pathways in untransformed human peripheral blood T lymphocytes.
Samstag Y; Nebl G
Adv Enzyme Regul; 2005; 45():52-62. PubMed ID: 16083947
[TBL] [Abstract][Full Text] [Related]
19. Signalling to actin: role of C3G, a multitasking guanine-nucleotide-exchange factor.
Radha V; Mitra A; Dayma K; Sasikumar K
Biosci Rep; 2011 Aug; 31(4):231-44. PubMed ID: 21366540
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the regulatory A subunit of serine/threonine protein phosphatase 2A in human breast cancer MCF-7 cells.
Suzuki K; Takahashi K
Int J Oncol; 2003 Nov; 23(5):1263-8. PubMed ID: 14532964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
